Therapeutic Options for Unscheduled Bleeding on Hormonal Contraception

Area of Science:

• Reproductive Health
• Pharmacology

Background:

• Unscheduled bleeding is a frequent adverse effect of hormonal contraceptives, frequently causing users to discontinue their use.
• Effective management strategies are essential for improving user adherence and satisfaction with hormonal contraception.

Purpose of the Study:

• To review current and potential therapeutic interventions for managing unscheduled bleeding in individuals using hormonal contraceptives.
• To evaluate the efficacy of established and novel agents in reducing breakthrough bleeding episodes.

Main Methods:

• Literature review of studies investigating treatments for unscheduled bleeding associated with hormonal contraceptives.
• Analysis of evidence for non-steroidal anti-inflammatory drugs (NSAIDs), hormonal therapies, and alternative agents such as doxycycline, mifepristone, tranexamic acid, tamoxifen, ulipristal acetate, and clomiphene citrate.

Main Results:

• Non-steroidal anti-inflammatory drugs (NSAIDs) and combined oral contraceptives containing estrogen and progestin are standard treatments.
• Preliminary evidence suggests that mifepristone and tranexamic acid may be effective for users of depot medroxyprogesterone acetate, implants, and intrauterine devices.
• Several other agents, including doxycycline, tamoxifen, ulipristal acetate, and clomiphene citrate, have shown potential in small studies.

Conclusions:

• Comprehensive counseling is vital for managing user expectations and improving satisfaction with hormonal contraceptives.
• While NSAIDs and combined oral contraceptives are common, alternative therapies warrant further investigation for managing persistent unscheduled bleeding.
• Mifepristone and tranexamic acid demonstrate particular promise for specific contraceptive methods, though more research is needed.